ImmunityBio Inc

NAS:IBRXHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$8.42−8.28%At closeAt close · Tue 20 Oct · ≈ AED 30.92 · Market cap $8.92B · Next earnings Tue 3 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	99.3%	—	—
Operating margin	−36,509.1%	−35,361.9%	−146,374.2%	−58,239.5%	−2,334.2%	−226.0%	−226.0%	+0.0 pts
Net margin	−36,669.6%	−37,129.6%	−173,569.6%	−93,761.4%	−2,804.8%	−310.2%	−310.2%	+0.0 pts
EBITDA margin	−33,755.4%	−34,341.8%	−146,617.1%	−76,955.5%	−1,793.4%	−197.3%	—	—
Return on equity	185.2%	143.2%	93.1%	99.4%	84.6%	70.3%	70.3%	+0.0 pts
Return on assets	−100.2%	−74.0%	−115.0%	−115.6%	−108.0%	−70.0%	−70.0%	+0.0 pts
Return on capital employed	−144.1%	−330.6%	253.6%	−81.2%	−104.9%	−58.2%	—	—
Debt / equity	−2.3×	−2.7×	−1.6×	−1.2×	−1.0×	−1.8×	−1.8×	+0.0%
Debt / assets	124.5%	137.7%	199.7%	144.1%	131.7%	175.0%	—	—
Interest coverage	−24.3×	−22.2×	−7.5×	−4.2×	−2.6×	−2.3×	—	—
Current ratio	1.6×	0.9×	0.3×	5.0×	3.4×	5.1×	5.1×	+0.0%
Quick ratio	1.6×	0.9×	0.3×	5.0×	3.2×	5.1×	—	—
Cash ratio	0.5×	0.5×	0.2×	4.6×	2.6×	1.4×	1.4×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.2×	—	—
Inventory turnover	—	—	—	—	0.0×	0.8×	—	—
Receivables turnover	0.3×	0.7×	0.1×	0.2×	5.6×	2.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.